Genomics is transforming modern infectious disease surveillance, expanding our understanding of pathogen evolution, host–pathogen interactions, and antibiotic resistance. In turn, public health professionals are changing the methods they use to research, monitor, and prevent epidemics and pandemics of high-profile infectious diseases such as influenza, tuberculosis, Ebola, and more recently, coronavirus.
Traditional methods of assessing infectious agents include antibody-based testing, real-time PCR, pulsed field gel electrophoresis, and multilocus sequence typing. These methods are typically useful only for a small and defined number of organisms, and data analysis can be subjective. In contrast, next-generation sequencing (NGS) provides a universal, hypothesis-free method for infectious disease surveillance that may be used with viruses, bacteria, fungi, or parasites, and can replace the need for multiple tests.
Illumina NGS is uniquely positioned in an infectious disease surveillance and outbreak model. Compare NGS methods and find solutions to detect and characterize SARS-CoV2, track transmission routes, study co-infection, and investigate viral evolution.Learn More
A rapid target enrichment sequencing workflow for highly sensitive detection and characterization of respiratory viruses, including COVID-19 strains.Read Application Note
Detection of respiratory viruses including coronavirus in <24 hours.Read Application Note
Rapid target enrichment workflow for broad detection of respiratory pathogens (including SARS-CoV-2 and flu viruses) and antimicrobial resistance genes.Read Application Note
This pandemic has underscored the need for new tools to detect, diagnose, and monitor emerging pathogens like SARS-CoV-2. Together with the Illumina respiratory virus oligo probe (RVOP) enrichment panel, this customized Explify RVOP application from IDbyDNA provides a sample-to-result solution for clinical metagenomics.View Webinar
The Explify Platform is a fully supported NGS-based, clinical metagenomics technology suite for clinical laboratories. Watch this video for a virtual tour to better understand how the Explify Platform streamlines processes, supports labs, improves results, and much, much more.Watch Video
The partnership aims to accelerate and improve testing for emerging public health threats like SARS-Cov-2.Read More
NGS technology enabled infectious disease experts to identify and characterize the genome of the novel coronavirus in China.Read Review
Chief Medical Officer, Phil Febbo, MD, discusses how public officials follow the path of the epidemic and what that means for tracking the spread of coronavirus mutations.Read More
This summary highlights recent peer-reviewed publications in which researchers used NGS to analyze viral populations, microbial pathogenesis, zoonotic reservoirs, the gut microbiome, and more.Read Review
Genomic analysis with NGS provides high-resolution information to distinguish pathogen strains that differ by as little as one single-nucleotide polymorphism (SNP). It also allows identification of both novel and known infectious agents.
Illumina NGS technology delivers rapid results and high-quality data that public health professionals are utilizing to identify, track, and respond to infectious disease outbreaks.